Estimation and correlation of serum folic acid levels in spina bifida babies and their mothers

Journal of Pediatric Neurosciences

Volumn 3, Issue 2, 2008, Pages 134-137

  Gupta, D ^a   Pandey, A ^a   Gangopadhyay, A ^a   Prasad, S ^a   Singh, T ^a   Khanna, H ^a   Upadhyaya, V ^a  

^a BANARAS HINDU UNIVERSITY   (India)

Author keywords

Folic acid; Neural tube defect; Spina bifida

Indexed keywords

FOLIC ACID;

ARTICLE; BLOOD SAMPLING; CLINICAL ARTICLE; CONTROLLED STUDY; DEMOGRAPHY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLIC ACID BLOOD LEVEL; HUMAN; INFANT; MALE; NEWBORN; PRENATAL DIAGNOSIS; SPINA BIFIDA;

EID: 55549126282     PISSN: 18171745     EISSN: 19983948     Source Type: Journal    
DOI: 10.4103/1817-1745.43640     Document Type: Article

References (18)

1. Bol KA, Collins JS, Kirby RS; National Birth Defects Prevention Network. Survival of infants with neural tube defects in the presence of folic acid fortification. Pediatrics 2006;117:803-13.
2. th ed. Mosby; Elsevier; 2006. p. 1987-2017.
3. Hibbard BM. The role of folic acid in pregnancy-with particular reference to anaemia, abruption and abortion. J Obstet Gynaecol Br Common 1964;71:529-42.
4. Green NS. Folic acid supplementation and prevention of birth defects. J Nutr 2002;132:2356S-60S.
5. Smithells RW, Sheppard S, Schorah CJ, Seller MJ, Nevin NC, Harris R, et al. Possible prevention of neural-tube defects by periconceptional vitamin supplementation. Lancet 1980;1:339-40.
6. Mulinare J, Cordero JF, Erickson JD, Berry RJ. Periconceptional use of multivitamins and the occurrence of neural tube defects. JAMA 1988;260:3141-5.
7. Milunsky A, Jick H, Jick SS, Bruell CL, MacLaughlin DS, Rothman KJ, et al. Multivitamin/folic acid supplementation in early pregnancy reduces the prevalence of neural tube defects. JAMA 1989;262:2847-52.
8. Bower C, Stanley FJ. Dietary folate as a risk factor for neural-tube defects: Evidence from a case-control study in Western Australia. Med J Aust 1989;150:613-9.
9. Werler MM, Shapiro S, Mitchell AA. Periconceptional folic acid exposure and risk of occurrent neural tube defects. JAMA 1993;269:1257-61.
10. Shaw GM, Schaffer D, Velie EM, Morland K, Harris JA. Periconceptional vitamin use, dietary folate, and the occurrence of neural tube defects in California. Epidemiology 1995;6:219-26.
11. Czeizel AE, Dudas I. Prevention of the first occurrence of neural tube defects by periconceptional vitamin supplementation. N Engl J Med 1992;327:1832-5.
12. MRC Vitamin Study Research Group. Prevention of neural tube defects. Lancet 1991;338:131-7.
13. Mills JL, Rhoads GG, Simpson JL, Cunningham GC, Conley MR, Lassman MR, et al. The absence of a relation between the periconceptional use of vitamins and neural-tube defects. N Engl J Med 1989;321:430-5.
14. Berry RJ, Li Z, Erickson JD, Li S, Moore CA, Wang H, et al. Prevention of neural-tube defects with folic acid in China: China-US collaborative project for neural tube defect prevention. N Engl J Med 1999;341:1485-90.
15. Mooij PN, Steegers-Theunissen RP, Thomas CM, Doesburg WH, Eskes TK. Periconceptional vitamin profiles are not suitable for identifying women at risk for neural tube defects. J Nutr 1993;123:197-203.
16. Smithells RW, Sheppard S, Schorah CJ. Vitamin deficiencies and neural tube defects. Arch Dis Child 1976;51:994-50.
17. Kirke PN, Molloy AM, Daly LE, Burke H, Weir DG, Scott JM. Maternal plasma folate and vitamin B12 are independent risk factors for neural tube defects. Q J Med 1993;86:703-8.
18. Lucock MD, Wild J, Schorah GI, Levene MI, Hartley R. The methylfolate axis in neural tube defects: In vitro characterization and clinical investigation. Rimhem Med Metab Eiol 1994;52:101-4